State Street Corp Summit Therapeutics Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 4,851,388 shares of SMMT stock, worth $135 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,851,388
Previous 5,602,910
13.41%
Holding current value
$135 Million
Previous $100 Million
6.43%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SMMT
# of Institutions
239Shares Held
88MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$681 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$325 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$220 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$183 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$91.6 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.61B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...